Biocartis announced the launch of its real-time quantitative polymerase chain reaction assay to detect POLE and POLD1 ...

ABL Diagnostics (FR001400AHX6 – ABLD, the“Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. ( ).

Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay ...

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them ...

QIAGEN N.V. today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts. This new solution combines sample preparation ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

Creative Diagnostics, a global provider of reagents and analytical services, has released its innovative Gene Copy Number ...

The Saluggia, Italy-based firm said that the Simplexa C. auris Direct kit is a real-time PCR assay that is used for the detection of DNA from six clades of the fungal pathogen in a composite ...

Five deaths were considered to be due to scrub typhus on the basis of a positive qPCR assay (in 3 deaths) or an IgM-positive ELISA in the presence of an eschar (in 2 deaths). Mortality was 0.09 ...